Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.
about
Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locusThe ankyrin repeat as molecular architecture for protein recognitionStructure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activityBiallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblastsAbsence of p16INK4a and truncation of ARF tumor suppressors in chickens.CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutationRare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related statesRegulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.Classifying variants of CDKN2A using computational and laboratory studies.INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescenceContrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors.Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.USP11 deubiquitinates RAE1 and plays a key role in bipolar spindle formation.Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effectA single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families
P2860
Q24317899-30A39BE2-1679-46CE-AB52-8A92C75BD168Q24646394-7FF76B94-A7CC-44A3-BA32-582E187A3016Q27639756-34A038CF-64D6-4932-9AB3-F328EECD7185Q34286570-3308A129-7C4E-478F-A4EF-7469ED2C8472Q34467363-AC42AC88-A559-47B0-932C-4657530DE5ABQ36643400-82B5BC2C-37B4-4476-B1A1-69205940FC29Q37198026-546E66BA-40B1-4580-86C9-6D2B06A08B59Q37880852-B92CCC2D-14DD-4E1E-84E5-46A013B58AC6Q38717030-7900E77F-380A-4253-AB14-E2944CF6684BQ39564985-C1048E3A-DCA5-4480-8B64-B0EEAB1ADDE8Q39647398-B759E7C4-9755-4622-B887-626D29435771Q41980817-5F92FAE2-40E9-4CCC-B39D-A0BC1A671A04Q42132289-02A8D2BE-C178-4DED-9757-EF8A558CAB12Q45737789-B29BDE52-B39D-415F-A558-EDD3769CC92BQ47238717-AAEF448B-70E6-4520-8320-14048E484CE1Q56893701-8B1B62EE-AC88-4799-98B1-D3FE72BEFD9BQ57499970-63625ACA-E8E4-4217-9912-29CC31689CEB
P2860
Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Functional evaluation of tumou ...... protein structure information.
@ast
Functional evaluation of tumou ...... protein structure information.
@en
type
label
Functional evaluation of tumou ...... protein structure information.
@ast
Functional evaluation of tumou ...... protein structure information.
@en
prefLabel
Functional evaluation of tumou ...... protein structure information.
@ast
Functional evaluation of tumou ...... protein structure information.
@en
P2093
P2860
P356
P1433
P1476
Functional evaluation of tumou ...... protein structure information.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1202918
P407
P577
1999-09-01T00:00:00Z
P5875
P6179
1051366864